Table 1 Clinical and laboratory data of patients who had HSCT in the BMT unit

Type of transplantation

Autologous

88 (46%)

Allogeneic

102 (54%)

Type of illness

Multiple myeloma

47(24.7%)

AML

44(23.1%)

Lymphoma

41(21.5%)

ALL

30(15.7%)

Severe aplastic anemia

16 (8.4%)

Chronic myeloid leukemia

7 (3.7%)

Myelodysplastic syndrome

5 (2.6%)

Virology pre-transplant

HBV

31(16.3%)

HCV

36 (19%)

CMV

15 (8%)

Mobilization protocol

VAD

23(22.3%)

DHAP

38(36.9%)

Velcade/dexamethasone

31(30.1%)

Endoxan/G-CSF

38(36.9%)

Conditioning regimen for autologous transplant

Melphalan

45(51.1%)

Carboplatin/VP16/CY

19(21.5%)

Melphalan/VP16

16(14.7%)

Conditioning regimen for allogeneic transplant

BU +FLU

51 (50%)

BU +CY

16(15.6%)

TBI +CY

13(12.7%)

CY+FLU+ATG

10 (9.8%)